NLS Pharmaceutics (NLSP) Stock Chart & Stock Price History $1.87 -0.06 (-3.11%) Closing price 02/7/2025 04:00 PM EasternExtended Trading$1.90 +0.03 (+1.87%) As of 02/7/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends NLS Pharmaceutics Stock Price Performance 5 Day Performance-13.82%1 Month Performance-22.41%3 Month Performance-52.54%6 Month Performance+867.91%Year-To-Date Performance-11.37%1 Year Performance+274.00% Receive NLSP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NLS Pharmaceutics and its competitors with MarketBeat's FREE daily newsletter. Email Address NLSP Stock Chart for Saturday, February, 8, 2025 NLSP Chart by TradingView NLS Pharmaceutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization02/07/2025$1.93$1.87-3.11%$1.96$1.81158,589 shs$7.14 million02/06/2025$1.98$1.93-2.53%$2.02$1.90127,234 shs$7.37 million02/05/2025$2.00$1.98-1.00%$2.14$1.97192,673 shs$7.56 million02/04/2025$2.17$2.00-7.83%$2.25$1.96228,825 shs$7.64 million02/03/2025$2.49$2.17-12.85%$2.40$2.06741,505 shs$8.29 million01/31/2025$1.98$2.49+25.76%$3.37$2.2961.15 million shs$9.50 million01/30/2025$1.96$1.98+1.02%$2.02$1.85239,630 shs$7.56 million01/29/2025$1.88$1.96+4.26%$1.97$1.80303,553 shs$7.49 million01/28/2025$1.81$1.88+3.87%$2.06$1.716.37 million shs$7.18 million01/27/2025$1.78$1.81+1.69%$1.85$1.7554,659 shs$6.91 million Get the Latest News and Ratings for NLSP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NLS Pharmaceutics and its competitors with MarketBeat's FREE daily newsletter. 01/24/2025$1.86$1.78-4.30%$1.82$1.7480,446 shs$6.80 million01/23/2025$1.89$1.86-1.59%$1.89$1.7382,146 shs$7.11 million01/22/2025$1.90$1.89-0.53%$1.95$1.8478,047 shs$7.22 million01/21/2025$1.91$1.90-0.52%$2.02$1.84189,165 shs$7.26 million01/20/2025$1.91$1.91$2.05$1.89120,083 shs$7.30 million01/17/2025$2.04$1.91-6.37%$2.05$1.89120,083 shs$7.30 million01/16/2025$2.00$2.04+2.00%$2.08$1.87147,574 shs$7.79 million01/15/2025$2.03$2.00-1.48%$2.07$1.94152,515 shs$7.63 million01/14/2025$2.07$2.03-1.93%$2.09$1.98105,795 shs$7.74 million01/13/2025$2.32$2.07-10.78%$2.19$1.96194,443 shs$7.90 million01/10/2025$2.41$2.32-3.73%$2.39$2.07458,869 shs$8.85 million01/09/2025$2.41$2.41$2.70$2.2017.50 million shs$9.19 million01/08/2025$2.06$2.41+16.99%$2.70$2.2017.50 million shs$9.19 million01/07/2025$2.09$2.06-1.44%$2.14$2.0469,352 shs$7.86 million Related Companies RenovoRx Stock Price Chart Grace Therapeutics Stock Price Chart Incannex Healthcare Stock Price Chart JATT Acquisition Stock Price Chart Akari Therapeutics Stock Price Chart MiNK Therapeutics Stock Price Chart Lexaria Bioscience Stock Price Chart Chemomab Therapeutics Stock Price Chart CytoMed Therapeutics Stock Price Chart Xilio Therapeutics Stock Price Chart Receive NLSP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NLS Pharmaceutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NLSP) was last updated on 2/8/2025 by MarketBeat.com Staff From Our PartnersMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredThis Crypto Is Set to Explode in JanuaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredThe Secret Winner in Trump’s AI RevolutionTrump just announced a $500 billion plan to revolutionize artificial intelligence. He's calling it The Star...Behind the Markets | SponsoredCould 1 of these 5 “America First” stocks 26x from here?Tim Bohen says these 5 tiny “America First” stocks are next up in 2025. They’re trading for less than $2 ri...Timothy Sykes | SponsoredElon Musk’s secret rendezvous with Jensen HuangElon Musk is the world's richest person, and it's not even close. Now he's got the ear of President Trump, ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NLS Pharmaceutics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share NLS Pharmaceutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.